ORGO

Organogenesis Holdings Inc (ORGO)

US
$ 3.7-4.88%

Price Chart

Key Statistics

Market Cap
$ 399.59M
P/E Ratio
0.00
Revenue (TTM)
$ 458.76M
Volume
1.1M
52W High
$ 6.71
52W Low
$ 2.28
Dividend Yield
0.00%
Beta
1.85

Technicals

50-Day MA
4.5952
200-Day MA
3.5701
52 Week High
6.71
52 Week Low
2.28

About ORGO

Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United St.

Employees
869
Headquarters
Canton, MA
CEO
Mr. Gary S. Gillheeney Sr.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg